KORU Medical Systems, Inc. (KRMD) vs Pyxis Oncology, Inc. (PYXS)
A side-by-side comparison of KORU Medical Systems, Inc. and Pyxis Oncology, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
KRMD
KORU Medical Systems, Inc.
$3.00HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
PYXS
Pyxis Oncology, Inc.
$2.02HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — KRMD vs PYXS
growth of $100 · dividends reinvested · last 5yKRMD +5.6% (+1.1%/yr)PYXS -83.0% (-29.9%/yr)KRMD compounded faster over this window
Log scale — wide-divergence pair
KRMD PYXS
KRMD vs PYXS: by the numbers
- •KRMD is the larger company ($138M vs $128M market cap).
- •Both run net losses; KRMD's is the smaller (-4.03% vs -803.83% net margin).
Metrics side by side
Valuation
| Metric | KRMD | PYXS |
|---|---|---|
| P/S ratio | 3.05 | 11.59 |
| P/B ratio | 7.63 | 11.19 |
| FCF yield | 0.19% | N/A |
Profitability
| Metric | KRMD | PYXS |
|---|---|---|
| Gross margin | 61.99% | 82.77% |
| Operating margin | -3.66% | -609.18% |
| Net margin | -4.03% | -803.83% |
| ROE | -10.08% | -775.59% |
| ROIC | -7.95% | -314.66% |
Growth (annualized)
| Metric | KRMD | PYXS |
|---|---|---|
| Revenue CAGR (5Y) | 16.42% | N/A |
| Total return CAGR (5Y) | 1.60% | N/A |
Go deeper
Dig into the metrics
KORU Medical Systems ROEPyxis Oncology ROEKORU Medical Systems operating marginPyxis Oncology operating marginKORU Medical Systems revenue growthPyxis Oncology revenue growthKORU Medical Systems free cash flowPyxis Oncology free cash flow
KORU Medical Systems & Pyxis Oncology appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.